<DOC>
	<DOCNO>NCT01147003</DOCNO>
	<brief_summary>This study ass efficacy safety BGG492 adjunctive treatment patient partial onset seizure .</brief_summary>
	<brief_title>Efficacy Safety BGG492 Adjunctive Treatment Patients With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<criteria>Outpatients ≥ 50 kg ( 110 lb ) weight . A diagnosis epilepsy ( ≥ 2 year prior screen ) partial seizure without secondarily generalize seizure . Uncontrolled partial seizure despite treat least two different antiepileptic drug ( AEDs ) within last 2 year prior screen . At least 4 partial seizure 4week baseline period least 4 partial seizure 4 week prior baseline period . Cohort 1 patient must receive stable treatment 1 maximum 2 AEDs.Cohort 2 patient must receive stable treatment 1 , 2 , 3 AEDs . Presence nonmotor simple partial seizure . History psychogenic seizure . Absences , myoclonic seizure e.g . context primary generalize epilepsy . Previous history LennoxGastaut syndrome . Status epilepticus seizure cluster , accord judgement investigator , occur within 52 week prior randomization . Pregnant nursing ( lactate ) woman . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Seizure frequency</keyword>
	<keyword>nervous system disease</keyword>
	<keyword>brain disease</keyword>
	<keyword>neurologic manifestation</keyword>
	<keyword>adjunctive treatment</keyword>
	<keyword>AEDs</keyword>
	<keyword>antiepileptic drug</keyword>
</DOC>